Several studies in various model systems of intrinsic tumor immunity or anti-tumor immunity associated with cancer immunotherapies demonstrated differential requirements for CD4+ Th cells during primary CTL responses, thereby resulting in the categorization of CTL responses as Th-dependent or Th-independent [12]–[14]. The gene discussed is CD4; the disease is cancer.